Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Polaryx Therapeutics, Inc. Common Stock
Market Cap
$103.68M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.72M
Operating Margin
28.39%
TTM Avg
14.20%
3Y Avg
7.10%
5Y Avg
4.73%
Market Cap
$106.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$105.20M
Operating Margin
-8.52%
TTM Avg
-145.19%
3Y Avg
-110.33%
5Y Avg
-78.53%
Market Cap
$104.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1310.83%
5Y Avg
-1301.48%
Market Cap
$107.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1578.22%
Market Cap
$107.19M
Operating Margin
-4744.25%
TTM Avg
-2372.13%
3Y Avg
-1186.06%
5Y Avg
-790.71%
Market Cap
$103.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. Common Stock (PLYX) | $103.68M | 0.00% | 0.00% | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $105.72M | 28.39% | 14.20% | 7.10% | 4.73% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | -8.52% | -145.19% | -110.33% | -78.53% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | 0.00% | 0.00% | -1310.83% | -1301.48% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | 0.00% | 0.00% | 0.00% | -1578.22% |
| Immunic, Inc. (IMUX)vs › | $107.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.19M | -4744.25% | -2372.13% | -1186.06% | -790.71% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| The Joint Corp. (JYNT)vs › | $102.21M | 2.45% | -2.63% | -0.94% | 2.21% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
